Company intelligence / Profile preview

Antibody Analytics

Motherwell, Scotland, United Kingdomrouken.bio ↗

Ownership: Private
Employees: ~83
Development stage: Other

Overview

Provides advanced in vitro testing, bioassay development, and analytical services supporting discovery and preclinical characterization of therapeutics—especially antibodies and novel biologics. No direct clinical results as it does not develop its own drugs.

Therapeutic areas: OncologyImmunology
Modalities: Monoclonal antibodyAntibody-drug conjugateCell therapySmall moleculePeptidesRecombinant proteinNanoparticle
Industry: Contract Research Organization

Partnerships

HistologiX (cellular/digital pathology partnership)

Beyond the preview

Go deeper on Antibody Analytics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Antibody Analytics.

Explore the full profile